IBDEI0IO ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8402,1,3,0)
 ;;=3^Balanoposthitis
 ;;^UTILITY(U,$J,358.3,8402,1,4,0)
 ;;=4^N47.6
 ;;^UTILITY(U,$J,358.3,8402,2)
 ;;=^12530
 ;;^UTILITY(U,$J,358.3,8403,0)
 ;;=N48.1^^39^398^4
 ;;^UTILITY(U,$J,358.3,8403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8403,1,3,0)
 ;;=3^Balanitis
 ;;^UTILITY(U,$J,358.3,8403,1,4,0)
 ;;=4^N48.1
 ;;^UTILITY(U,$J,358.3,8403,2)
 ;;=^12525
 ;;^UTILITY(U,$J,358.3,8404,0)
 ;;=N52.34^^39^398^43
 ;;^UTILITY(U,$J,358.3,8404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8404,1,3,0)
 ;;=3^Erectile Dysfunction Following Simple Prostatectomy
 ;;^UTILITY(U,$J,358.3,8404,1,4,0)
 ;;=4^N52.34
 ;;^UTILITY(U,$J,358.3,8404,2)
 ;;=^5015760
 ;;^UTILITY(U,$J,358.3,8405,0)
 ;;=N52.39^^39^398^45
 ;;^UTILITY(U,$J,358.3,8405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8405,1,3,0)
 ;;=3^Erectile Dysfunction Post-Surgical,Other & Unspec
 ;;^UTILITY(U,$J,358.3,8405,1,4,0)
 ;;=4^N52.39
 ;;^UTILITY(U,$J,358.3,8405,2)
 ;;=^5015761
 ;;^UTILITY(U,$J,358.3,8406,0)
 ;;=N52.33^^39^398^44
 ;;^UTILITY(U,$J,358.3,8406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8406,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,8406,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,8406,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,8407,0)
 ;;=N52.32^^39^398^41
 ;;^UTILITY(U,$J,358.3,8407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8407,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,8407,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,8407,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,8408,0)
 ;;=N52.31^^39^398^42
 ;;^UTILITY(U,$J,358.3,8408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8408,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,8408,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,8408,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,8409,0)
 ;;=N52.2^^39^398^48
 ;;^UTILITY(U,$J,358.3,8409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8409,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,8409,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,8409,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,8410,0)
 ;;=N52.03^^39^398^39
 ;;^UTILITY(U,$J,358.3,8410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8410,1,3,0)
 ;;=3^Erectile Dysfunction Comb Artrl Insuff & Corporo-Venous Occlusv
 ;;^UTILITY(U,$J,358.3,8410,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,8410,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,8411,0)
 ;;=N52.02^^39^398^40
 ;;^UTILITY(U,$J,358.3,8411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8411,1,3,0)
 ;;=3^Erectile Dysfunction Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,8411,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,8411,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,8412,0)
 ;;=N52.1^^39^398^47
 ;;^UTILITY(U,$J,358.3,8412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8412,1,3,0)
 ;;=3^Erectile Dysfunction d/t Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,8412,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,8412,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,8413,0)
 ;;=N52.01^^39^398^46
 ;;^UTILITY(U,$J,358.3,8413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8413,1,3,0)
 ;;=3^Erectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,8413,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,8413,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,8414,0)
 ;;=N95.2^^39^398^90
 ;;^UTILITY(U,$J,358.3,8414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8414,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
